In May 2018, Strides Pharma Science and Apotex Inc. announced their intention to merge Arrow Pharmaceuticals and Apotex Australia into a new company.
The transaction remains subject to the conclusion of definitive agreements, Board approval and the satisfaction of certain other conditions, including approval from the Australian Foreign Investment Review Board.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)